Lenz Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
LENZ Therapeutics will hold its annual stockholders meeting on June 10, 2025, to elect directors and ratify the appointment of Ernst & Young LLP as the independent auditor.
NASDAQ
LENZ Therapeutics announces its annual meeting of stockholders to be held virtually on June 10, 2025, to elect directors and ratify the appointment of its independent accounting firm.